litlas
Log inCreate account

Hiroshi Mitsumoto

Active 1975–2025

103
Papers
19,702
Citations
79
h-index
98
i10-index

Citations

Citations per year for Hiroshi Mitsumoto1951: 10 citations1977: 5 citations1978: 1 citations1980: 1 citations1981: 1 citations1982: 1 citations1983: 2 citations1984: 1 citations1985: 3 citations1986: 3 citations1987: 1 citations1988: 4 citations1989: 5 citations1990: 6 citations1991: 10 citations1992: 12 citations1993: 17 citations1994: 12 citations1995: 31 citations1996: 25 citations1997: 25 citations1998: 25 citations1999: 30 citations2000: 47 citations2001: 58 citations2002: 55 citations2003: 50 citations2004: 53 citations2005: 47 citations2006: 83 citations2007: 103 citations2008: 114 citations2009: 243 citations2010: 213 citations2011: 222 citations2012: 184 citations2013: 224 citations2014: 238 citations2015: 210 citations2016: 220 citations2017: 192 citations2018: 134 citations2019: 515 citations2020: 602 citations2021: 550 citations2022: 390 citations2023: 290 citations2024: 433 citations2025: 175 citations2026: 3 citations1952–1976: no citations, so these years are not shown1979: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 1,833 citing papers, 27% of this breakdownUnited Kingdom: 642 citing papers, 9.4% of this breakdownItaly: 499 citing papers, 7.3% of this breakdownGermany: 378 citing papers, 5.6% of this breakdownAustralia: 311 citing papers, 4.6% of this breakdownChina: 310 citing papers, 4.6% of this breakdownCanada: 291 citing papers, 4.3% of this breakdownFrance: 283 citing papers, 4.2% of this breakdownJapan: 242 citing papers, 3.5% of this breakdownNetherlands: 204 citing papers, 3% of this breakdownSpain: 179 citing papers, 2.6% of this breakdownIndia: 127 citing papers, 1.9% of this breakdown
0%27%Other 22%

Institutions

Fields

  • Medicine66.6%
  • Biochemistry, Genetics and Molecular Biology16.4%
  • Neuroscience8.4%
  • Computer Science3.9%
  • Engineering1.2%
  • Health Professions0.9%
  • Other2.6%

Topics

  • Amyotrophic Lateral Sclerosis Research18.5%
  • Neurogenetic and Muscular Disorders Research9.3%
  • Parkinson's Disease Mechanisms and Treatments4.4%
  • Genetic Neurodegenerative Diseases3.2%
  • Pluripotent Stem Cells Research3%
  • Alzheimer's disease research and treatments2.8%
  • Other58.8%

Coauthors

All papers

Open in search
  1. A proposal for new diagnostic criteria for ALS

    Authors: Jeremy M. Shefner, Ammar Al‐Chalabi, Mark R. Baker, Liying Cui, Mamede de Carvalho, Andrew Eisen, Julian Großkreutz, Orla Hardiman, Robert D. Henderson, José Manuel Matamala, Hiroshi Mitsumoto, Walter J. Paulus, Neil G. Simon, Michael Swash, Kevin Talbot, Martin R. Turner, Yoshikazu Ugawa, Leonard H. van den Berg, Renato J. Verdugo, S. Vucic, Ryuji Kaji, David Burke, Matthew C. Kiernan - Clinical Neurophysiology 2020 cited by 574

  2. Electrodiagnostic criteria for diagnosis of ALS

    Authors: Mamede de Carvalho, Reinhard Dengler, Andrew Eisen, John D. England, Ryuji Kaji, Jun Kimura, Kerry Mills, Hiroshi Mitsumoto, Hiroyuki Nodera, Jeremy M. Shefner, Michael Swash - Clinical Neurophysiology 2008 cited by 1,177

  3. Practice Parameter update: The care of the patient with amyotrophic lateral sclerosis: Drug, nutritional, and respiratory therapies (an evidence-based review)[RETIRED]

    Authors: Robert G. Miller, Carlayne E. Jackson, Edward J. Kasarskis, J. D. England, Dalles A. Forshew, Wendy Johnston, Sanjay Kalra, J. S. Katz, Hiroshi Mitsumoto, Jeffrey Rosenfeld, C. Shoesmith, Michael J. Strong, Susan Woolley - Neurology 2009 cited by 808

  4. Primary lateral sclerosis: consensus diagnostic criteria

    Authors: Martin R. Turner, Richard J. Barohn, Philippe Corcia, John K. Fink, Matthew B. Harms, Matthew C. Kiernan, John Ravits, Vincenzo Silani, Zachary Simmons, Jeffrey Statland, Leonard H. van den Berg, Delegates of the 2nd International PLS Conference, Hiroshi Mitsumoto - Journal of Neurology Neurosurgery & Psychiatry 2020 cited by 244

  5. Necroptosis Drives Motor Neuron Death in Models of Both Sporadic and Familial ALS

    Authors: Diane B. Ré, Virginia Le Verche, Changhao Yu, Mackenzie W. Amoroso, Kristin A. Politi, Sudarshan Phani, Burcin Ikiz, Lucas Hoffmann, Martijn Koolen, Tetsuya Nagata, Dimitra Papadimitriou, Péter L. Nagy, Hiroshi Mitsumoto, Shingo Kariya, Hynek Wichterle, Christopher E. Henderson, Serge Przedborski - Neuron 2014 cited by 404

  6. Induced Pluripotent Stem Cells Generated from Patients with ALS Can Be Differentiated into Motor Neurons

    Authors: John T. Dimos, Kit T. Rodolfa, Kathy K. Niakan, Laurin M. Weisenthal, Hiroshi Mitsumoto, Wendy K. Chung, Gist F. Croft, Genevieve Saphier, R.L. Leibel, Robin Goland, Hynek Wichterle, Christopher E. Henderson, Kevin Eggan - Science 2008 cited by 1,989

  7. Practice Parameter update: The care of the patient with amyotrophic lateral sclerosis: Multidisciplinary care, symptom management, and cognitive/behavioral impairment (an evidence-based review)

    Authors: Rupert G. Miller, Carlayne E. Jackson, Edward J. Kasarskis, J. D. England, Dallas Forshew, Wendy Johnston, Sanjay Kalra, J.S. Katz, Hiroshi Mitsumoto, Jeffrey Rosenfeld, C. Shoesmith, Michael J. Strong, Susan Woolley - Neurology 2009 cited by 659

  8. Clinical perspective on oxidative stress in sporadic amyotrophic lateral sclerosis

    Authors: Emanuele D’Amico, Pam Factor‐Litvak, Regina M. Santella, Hiroshi Mitsumoto - Free Radical Biology and Medicine 2013 cited by 314

  9. Phase II trial of CoQ10 for ALS finds insufficient evidence to justify phase III

    Authors: Petra Kaufmann, John L.P. Thompson, Gilberto Levy, Richard Buchsbaum, Jeremy M. Shefner, Lisa S. Krivickas, Jonathan Katz, Yvonne D. Rollins, Richard J. Barohn, Carlayne E. Jackson, Ezgi Tiryaki, Catherine Lomen‐Hoerth, Carmel Armon, Rup Tandan, Stacy A. Rudnicki, Kourosh Rezania, Robert Sufit, Alan Pestronk, Steven Novella, Terry Heiman‐Patterson, Edward J. Kasarskis, Erik P. Pioro, Jacqueline Montes, Rachel Arbing, Darleen Vecchio, Alexandra I. Barsdorf, Hiroshi Mitsumoto, Bruce Levin - Annals of Neurology 2009 cited by 235

  10. Lipidomics study of plasma from patients suggest that ALS and PLS are part of a continuum of motor neuron disorders

    Authors: Estela Área-Gómez, Delfina Larrea, Tianwei Yun, Yimeng Xu, Jonathan Hupf, Fereshteh Zandkarimi, Robin Chan, Hiroshi Mitsumoto - Scientific Reports 2021 cited by 63

  11. Efficacy of minocycline in patients with amyotrophic lateral sclerosis: a phase III randomised trial

    Authors: Paul H Gordon, Dan H. Moore, Robert G. Miller, Julaine Florence, Joseph L. Verheijde, Carolyn Doorish, Joan F. Hilton, G. Mark Spitalny, Robert B. MacArthur, Hiroshi Mitsumoto, Hans E. Neville, Khrista Boylan, Tahseen Mozaffar, Jerry M. Belsh, John Ravits, Richard Bedlack, Michael C. Graves, Leo McCluskey, Richard J. Barohn, Rup Tandan - The Lancet Neurology 2007 cited by 642

  12. Clinical trials in amyotrophic lateral sclerosis: why so many negative trials and how can trials be improved?

    Authors: Hiroshi Mitsumoto, Benjamin Rix Brooks, Vincenzo Silani - The Lancet Neurology 2014 cited by 288

  13. Controversies and priorities in amyotrophic lateral sclerosis

    Authors: Martin R. Turner, Orla Hardiman, Michael Benatar, Benjamin Rix Brooks, Adriano Chiò, Mamede de Carvalho, Paul G. Ince, Cindy Lin, Robert G. Miller, Hiroshi Mitsumoto, Garth A. Nicholson, John Ravits, Pamela J. Shaw, Michael Swash, Kevin Talbot, Bryan J. Traynor, Leonard H. van den Berg, Jan H. Veldink, Steve Vucic, Matthew C. Kiernan - The Lancet Neurology 2013 cited by 530

  14. Novel Mutations in TARDBP (TDP-43) in Patients with Familial Amyotrophic Lateral Sclerosis

    Authors: Nicola J. Rutherford, Yong‐Jie Zhang, Matt Baker, Jennifer Gass, NiCole A. Finch, Yafei Xu, Heather Stewart, Brendan Kelley, Karen M. Kuntz, Richard Crook, Jemeen Sreedharan, Caroline Vance, Eric J. Sorenson, Carol F. Lippa, Eileen H. Bigio, Daniel H. Geschwind, David S. Knopman, Hiroshi Mitsumoto, Ronald C. Petersen, Neil R. Cashman, Mike Hutton, Christopher E. Shaw, Khrista Boylan, Bradley F. Boeve, Neill R. Graff‐Radford, Zbigniew K. Wszołek, Richard J. Caselli, Dennis W. Dickson, Ian R. Mackenzie, Leonard Petrucelli, Rosa Rademakers - PLoS Genetics 2008 cited by 463

  15. Potential Environmental Factors in Amyotrophic Lateral Sclerosis

    Authors: Björn Oskarsson, D. Kevin Horton, Hiroshi Mitsumoto - Neurologic Clinics 2015 cited by 139

  16. Revised Airlie House consensus guidelines for design and implementation of ALS clinical trials

    Authors: Leonard H. van den Berg, Eric J. Sorenson, Gary Gronseth, Eric A. Macklin, Jinsy Andrews, Robert H. Baloh, Michael Benatar, James D. Berry, Adriano Chiò, Philippe Corcia, Angela Genge, Amelie K. Gubitz, Catherine Lomen‐Hoerth, Christopher McDermott, Erik P. Pioro, Jeffrey Rosenfeld, Vincenzo Silani, Martin R. Turner, Markus Weber, Benjamin Rix Brooks, Robert G. Miller, Hiroshi Mitsumoto - Neurology 2019 cited by 137

  17. The natural history of primary lateral sclerosis

    Authors: P. H. Gordon, Bin Cheng, Ilana Katz, Maria João Pinto, Arthur P. Hays, Hiroshi Mitsumoto, Lewis P. Rowland - Neurology 2006 cited by 367

  18. Hypercaloric enteral nutrition in patients with amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled phase 2 trial

    Authors: Anne‐Marie Wills, Jane Hubbard, Eric A. Macklin, Jonathan D. Glass, Rup Tandan, Ericka P. Simpson, Benjamin Rix Brooks, Deborah Gelinas, Hiroshi Mitsumoto, Tahseen Mozaffar, Gregory P. Hanes, Shafeeq Ladha, Terry Heiman‐Patterson, Jonathan Katz, Jau Shin Lou, Katy Mahoney, Daniela Grasso, Robert Lawson, Hong Yu, Merit Cudkowicz - The Lancet 2014 cited by 266

  19. Oxidative stress biomarkers in sporadic ALS

    Authors: Hiroshi Mitsumoto, Regina M. Santella, Xinhua Liu, Mikhail Bogdanov, Jennifer Zipprich, Hui‐Chen Wu, Julie Mahata, Mary Kilty, Kate Bednarz, Daniel Bell, Paul H. Gordon, Mady Hornig, Mahsa Mehrazin, Ali Naini, M. Flint Beal, Pam Factor‐Litvak - Amyotrophic Lateral Sclerosis 2008 cited by 177

  20. Deciphering amyotrophic lateral sclerosis: What phenotype, neuropathology and genetics are telling us about pathogenesis

    Authors: John Ravits, Stanley H. Appel, Robert H. Baloh, Richard J. Barohn, Benjamin Rix Brooks, Lauren Elman, Mary Kay Floeter, Christopher E. Henderson, Catherine Lomen‐Hoerth, Jeffrey D. Macklis, Leo McCluskey, Hiroshi Mitsumoto, Serge Przedborski, Jeffrey D. Rothstein, John Q. Trojanowski, Leonard H. van den Berg, Steven P. Ringel - Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 2013 cited by 170

  21. A microRNA diagnostic biomarker for amyotrophic lateral sclerosis

    Authors: Sandra Anne Banack, Rachael A. Dunlop, Paul Mehta, Hiroshi Mitsumoto, Stewart P Wood, Moon Han, Paul Alan Cox - Brain Communications 2024 cited by 28

  22. Metabolic Abnormalities, Dietary Risk Factors and Nutritional Management in Amyotrophic Lateral Sclerosis

    Authors: Emanuele D’Amico, Giuseppe Grosso, Jeri W. Nieves, Aurora Zanghì, Pam Factor‐Litvak, Hiroshi Mitsumoto - Nutrients 2021 cited by 57

  23. Amyotrophic lateral sclerosis: a long preclinical period?

    Authors: Andrew Eisen, Matthew C. Kiernan, Hiroshi Mitsumoto, Michael Swash - Journal of Neurology Neurosurgery & Psychiatry 2014 cited by 158

  24. Development and evaluation of a self-administered version of the ALSFRS-R

    Authors: Jacqueline Montes, Gilberto Levy, Steven M. Albert, P. Kaufmann, Richaro Buchsbaum, P. H. Gordon, Hiroshi Mitsumoto - Neurology 2006 cited by 99